Jupiter Hospital and MedGenome Join Forces to Launch Advanced Genomics Lab

Date:

Share post:

Jupiter Hospital has announced a strategic collaboration with MedGenome, a global leader in genomics, to launch the Jupiter–MedGenome Genomics Lab. This partnership aims to bridge the gap between advanced genomic science and routine clinical practice, marking a significant step forward in the hospital’s commitment to precision medicine.

The new genomics lab is designed to provide clinicians and patients with access to sophisticated genomic testing. By integrating cutting-edge genetic analysis into the hospital’s diagnostic framework, Jupiter Hospital seeks to enable more accurate disease detection, highly personalized treatment plans, and proactive preventative care.

“As healthcare continues to evolve, genomics is redefining the way diseases are detected, treated, and prevented,” stated a spokesperson for Jupiter Hospital. “Through this collaboration, we are strengthening our commitment to delivering world-class, technology-driven care tailored to each patient’s unique genetic profile.”

The initiative reflects a shared vision between Jupiter Hospital and MedGenome to drive innovation in healthcare, ensuring that clinical excellence is complemented by the latest advancements in medical genetics. The facility is now operational, providing specialized diagnostic services to patients seeking personalized therapeutic pathways.

Written by: Pragna Biswas

Graphics by: Pramit Hazra

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related articles

Bhawanipur Global Campus Announces iNATCONPH 2026: A Global Platform for Pharmacy & Allied Health Research

Kolkata: Bhawanipur Global Campus has announced the 16th International Conference - iNATCONPH 2026, a prestigious international scientific conference...

Emcure Pharma Receives CDSCO Approval to Launch Poviztra®️ for Fatty Liver Disease Treatment

Emcure Pharmaceuticals Ltd  announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs...

CDSCO Partners with THSTI to Strengthen Vaccine and Healthcare innovation

The Central Drugs Standard Control Organization (CDSCO), India’s national regulatory authority, and the Translational Health Science and Technology...

EMeRG Launches Hospital Intel Suite™️ to transform MedTech Market

EMeRG, a leading healthcare intelligence provider with over a decade of industry expertise,  announced the launch of Hospital...